MedPath

se of Fluorescence and Reflectance Imaging for diagnosis of abnormalities within the gastrointestinal tract

Phase 3
Conditions
Health Condition 1: C15-C26- Malignant neoplasms of digestive organs
Registration Number
CTRI/2021/01/030415
Lead Sponsor
Dr Stanley Mathew
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients above 18 years of age operated by the General Surgery Department of Kasturba Hospital, Manipal for gastrointestinal luminal malignancies during the study period

Exclusion Criteria

Age less than 18 years

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determine the utility of Fluorescence and diffuse reflectance imaging in the diagnosis of Gastrointestinal lesions.Timepoint: 15 days (to obtain the report of HPE and validate the diagnosis)
Secondary Outcome Measures
NameTimeMethod
1. Feasibility of identification of tumour free margins intraoperatively using Fluorescence and Diffuse reflectance. 2. Identification of premalignant lesions. <br/ ><br>3. Differentiating malignant from benign lesionsTimepoint: 15 days (to obtain the report of HPE and validate the diagnosis)
© Copyright 2025. All Rights Reserved by MedPath